Stay updated on Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the rebastinib–carboplatin study is now available, with study design, eligibility, locations, outcomes, and documents. It indicates that the study is terminated and no longer recruiting participants.
    Difference
    74%
    Check dated 2026-11-10T22:46:44.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The study record still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T22:51:45.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH transition notice appears above the study page, which still shows a 403 error instead of the study record. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:05:21.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T21:50:47.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the expected study record content and leaving the standard header and footer visible.
    Difference
    0.5%
    Check dated 2026-09-29T22:10:21.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the previous study details with an error screen. This is an access issue rather than a substantive update to the trial information.
    Difference
    22%
    Check dated 2026-09-23T00:10:21.000Z thumbnail image

Stay in the know with updates to Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.